The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A multicenter phase 1 trial of tucatinib, trastuzumab, and capecitabine with stereotactic radiosurgery in patients with brain metastases from HER-2–positive breast cancer (TUTOR).
 
Manmeet Singh Ahluwalia
Stock and Other Ownership Interests - doctible; MedInnovate Advisors LLC; MimiVax; TriSalus Life Sciences
Honoraria - Elsevier; Peerview; Prime Education; Prime Oncology
Consulting or Advisory Role - AlloVir; Anheart Therapeutics; Apollomics; Autem Therapeutics; Bayer; Bugworks; Cairn Therapeutics; Caris Life Sciences; Equillium; GlaxoSmithKline; InSightec; Janssen; Menarini Group; Modifi Bio; NH TherAguix; Nuvation Bio; Prelude Therapeutics; Pyramid Biosciences; SDP Oncology; Siemens Healhineers/Varian Medical Systems; Sumitomo Dainippon Pharma Oncology; ViewRay; Voyager Therapeutics; Xoft
Research Funding - Abbvie (Inst); AstraZeneca (Inst); Bayer (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); Incyte (Inst); Merck (Inst); MimiVax (Inst); Novartis (Inst); Novocure (Inst); Pharmacyclics (Inst); Seagen (Inst)
Other Relationship - Idorsia (I); ResMed (I)
 
Ahmad Ozair
No Relationships to Disclose
 
Mainak Bardhan
No Relationships to Disclose
 
Shreyas S Bellur
No Relationships to Disclose
 
Dilanis C. Perche
No Relationships to Disclose
 
Amy K. Starosciak
No Relationships to Disclose
 
Daniel S. Leon-Ariza
No Relationships to Disclose
 
Atulya Aman Khosla
No Relationships to Disclose
 
Muni Rubens
No Relationships to Disclose
 
Yazmin Odia
Consulting or Advisory Role - GammaTile; Istari; PharPoint Research
Research Funding - Bristol-Myers Squibb (Inst); Novocure (Inst)
(OPTIONAL) Uncompensated Relationships - Actuate Therapeutics; Chimerix
 
Minesh P. Mehta
Employment - Miami Cancer Institute
Stock and Other Ownership Interests - Chimerix
Consulting or Advisory Role - Kazia Therapeutics; Mevion Medical Systems; Novocure; Telix Pharmaceuticals; Xoft; ZappRx
Patents, Royalties, Other Intellectual Property - WARF patent 14/934,27, TOPICAL VASOCONSTRITOR PREPARATIONS AND METHODS FOR PROTECTING CELLS DURING CANCER CHEMOTHERAPY AND RADIOTHERAPY
(OPTIONAL) Uncompensated Relationships - Xcision Medical Systems
 
Rupesh Kotecha
Honoraria - Accuray; BrainLAB; Castle Biosciences; Elekta; Elsevier; IBA; Kazia Therapeutics; Peerview
Consulting or Advisory Role - Novocure; ViewRay
Speakers' Bureau - GT Medical Technologies (I); Novocure
Research Funding - AstraZeneca (Inst); Blue Earth Diagnostics (Inst); BrainLAB (Inst); Cantex Pharmaceuticals, Inc. (Inst); Exelixis (Inst); GT Medical Technologies (Inst); IBA (Inst); Medtronic (Inst); Novocure (Inst); ViewRay (Inst)
Travel, Accommodations, Expenses - BrainLAB; Elekta; Novocure; Peerview; ViewRay
Other Relationship - GT Medical Technologies Data Safety Monitoring Board; InSightec Advisory Board; Plus Therapeutics Data Safety Monitoring Board
 
Michael W McDermott
Honoraria - InSightec
Consulting or Advisory Role - Stryker
Patents, Royalties, Other Intellectual Property - Limitorr CSF
 
Ana Cristina Sandoval-Leon
Consulting or Advisory Role - AstraZeneca; Gilead Sciences; Guardant Health; Merck; Oncocyte; Sanofi/Aventis; Sermonix Pharmaceuticals; Stemline Therapeutics
Research Funding - AstraZeneca (Inst); OBI Pharma (Inst); Seagen (Inst)
 
Reshma L. Mahtani
Consulting or Advisory Role - Agendia; Amgen; Daiichi Sankyo/Astra Zeneca; Eisai; Genentech/Roche; Gilead Sciences; Hologic/Biotheranostics; Lilly; Merck; Novartis; Pfizer; Puma Biotechnology; Sanofi; Sermonix Pharmaceuticals; Stemline Therapeutics
Speakers' Bureau - Seattle Genetics/Astellas
Research Funding - Gilead Sciences (Inst)
Travel, Accommodations, Expenses - Agendia; Amgen; AstraZeneca; bioTheranostics; Daiichi Sankyo/Lilly; Eisai; Genentech/Roche; Lilly; Merck; Novartis; Pfizer; Puma Biotechnology; Sanofi; Seagen
 
David M. Peereboom
Honoraria - Novocure
Consulting or Advisory Role - Anheart Therapeutics; Neonc Technologies; Novocure; Orbus Therapeutics; SERVIER; Stemline Therapeutics
Research Funding - Apollomics (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Global Coalition for Adaptive Research (Inst); Karyopharm Therapeutics (Inst); MimiVax (Inst); Neonc Technologies (Inst); Novartis (Inst); Ono Pharmaceutical (Inst); Orbus Therapeutics (Inst); Pfizer (Inst); Pharmacyclics (Inst); Vigeo Therapeutics (Inst)
Travel, Accommodations, Expenses - Novocure
Other Relationship - IN8bio (Inst)